- $5.54bn
- $6.45bn
- $2.04bn
RadNet slides on pricing $225 mln stock offering
Brief: Radnet Announces Pricing Of Upsized Public Offering Of Common Stock
Brief: RadNet Announces Proposed $175 Mln Underwritten Public Offering Of Common Stock
RadNet Inc reports results for the quarter ended in March - Earnings Summary
Brief: RadNet Q1 EPS USD -0.36
Brief: Radnet Reports Q1 Financial Results And Revises Upwards 2023 Financial Guidance Ranges For Revenue And Adj. EBITDA
RadNet Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Radnet's Quantib B.V. Subsidiary Receives FDA Clearance For Its Quantib Prostate™ 3.0 Software
RadNet Inc reports results for the quarter ended in December - Earnings Summary
Brief: RadNet Reports Q4 Adjusted EPS Of $0.11
Brief: RadNet reports Q4 net loss per share of 0.02
RadNet Inc expected to post earnings of 15 cents a share - Earnings Preview
Brief: RadNet Files For Potential Mixed Shelf Offering
Brief: DeepHealth Announces FDA Clearance Of Its Third AI Mammography Product
Brief: Radnet's Aidence Artificial Intelligence Subsidiary & Google Health to Collaborate
RadNet slumps on downbeat Q3 profit; lowers EBITDA profit forecast
RadNet Inc reports results for the quarter ended in September - Earnings Summary
Brief: Radnet Reports Q3 Adjusted Profit of $0.09 Per Share
RadNet Inc expected to post earnings of 16cents a share - Earnings Preview